ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2038

Single Cell RNA Sequencing Points to a Role for Fibroblasts Early in Salivary Gland Dysfunction in Primary Sjögren’s Syndrome

Sarah Pringle1, Fred Spijkervet1, Arjan Vissink2, Hendrika Bootsma1 and Frans Kroese1, 1University Medical Center Groningen, Groningen, Netherlands, 2UMCG, Leek, Netherlands

Meeting: ACR Convergence 2022

Keywords: Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Salivary gland (SG) dysfunction is commonly associated with the autoimmune disease primary Sjögren’s syndrome (pSS). Whilst the more advanced stages of the disease are well studied, the earliest events triggering SG dysfunction remain enigmatic. We sought to elucidate the earliest events suggestive of SG dysfunction, using a non-biased single cell sequencing cell-interaction approach, and biopsies of the parotid SG.

Methods: Parotid gland biopsies were harvested from 12 SSA+ pSS patients grouped into those with with no infiltration (focus score (FS) =0, n=4), intermediate infiltration (FS 0-1, n=4) and a positive focus score (FS >1, n=4). Healthy parotid glands were also harvested (n=4). After digestion, single cell RNA sequencing was performed on all cells present in all biopsies. A total of 24,817 cells were sequenced. Every droplet with ≥500 UMIs was considered a cell. Cells with < 200 expressed genes were discarded, as were cells showing mitochondrial gene expression as >25% of total genes. Data was normalized and scaled in SCTransform, and Seurat and CellChat platforms used for further analysis.

Results: 24 broad cell types were identified in the total sequenced cells, broadly grouped into acinar cells, ductal cells, tissue macrophages and monocytes, B cells, T cells, plasma cells and fibroblasts. CellChat analysis suggested in FS=0 pSS group that there may be communication between fibroblasts and subsets of the T, B and monocytes. This hypothesized communication was absent or minimal in healthy control, pSS FS0-1 and pSS FS >1 groups. Further pathway analysis pinpointed CXCL12 ligand expression by fibroblasts and CXCR4 receptor by T and B cells and monocytes, in additional to the MIF pathway, as potentially active signaling pathways between the cell types.

In order to validate the immunogenic role of fibroblasts early in SG damage in pSS, we are in the process of establishing fibroblast cultures from FS=0 biopsies of pSS patients and comparing their transcriptomes, immunomodulatory capabilities and effect when co-cultured with T cells, B cells and saliva producing acinar cells.

Conclusion: Theoretical analysis based on single cell sequencing data would imply that fibroblast may occupy a central role in the initiation of SG dysfunction or damage in pSS patients. Further validation of this may help us understand how to target this early disease stage, and minimize gland dysfunction.


Disclosures: S. Pringle, None; F. Spijkervet, None; A. Vissink, None; H. Bootsma, Novartis, Bristol-Myers Squibb(BMS); F. Kroese, None.

To cite this abstract in AMA style:

Pringle S, Spijkervet F, Vissink A, Bootsma H, Kroese F. Single Cell RNA Sequencing Points to a Role for Fibroblasts Early in Salivary Gland Dysfunction in Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/single-cell-rna-sequencing-points-to-a-role-for-fibroblasts-early-in-salivary-gland-dysfunction-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-points-to-a-role-for-fibroblasts-early-in-salivary-gland-dysfunction-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology